2 recruiting, 1 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow L19IL2: new trials by email Literature Review of L19IL2 trials Research Report on L19IL2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) L19IL2, L19TNF, L19IL2/L19TNF - Locally Advanced Basal Cell Carcinoma | Phase 2 | Recruiting | Philogen S.p.A. | 180 | 2026-06-01 | 2026-07-31 |
| Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients L19IL2, L19TNF, L19IL2/L19TNF - Melanoma Stage III, Melanoma Stage IV | Phase 2 | Recruiting | Philogen S.p.A. | 162 | 2024-07-12 | 2026-09-02 |
| A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours L19IL2 - Advanced Solid Tumours | Phase 1 / Phase 2 | Completed | Philogen S.p.A. | 33 | 2005-11-01 | 2014-02-25 |
Carcinoma, Basal Cell (1) · Carcinoma, Renal Cell (1) · Melanoma (1)
Philogen S.p.A. (3)
Germany (3) · Italy (3) · United States (2) · Greece (1) · Spain (1)
Danielle Bello (1) · Filippo De Braud, Dr (1) · Manfred Johannsen, Dr (1)
2005 (1), 2025 (1)